The world is changing fast and to keep up you need local knowledge with global context.
As the FT’s foreign affairs columnist Gideon Rachman writes, China’s initially successful Covid lockdown approach has come back to haunt it.
Pfizer said that surging sales of its Covid-19 treatment and continued demand for its shots should boost the company’s revenue to around $100bn this year.
Here’s Jerm’s take on the now public Fauci emails, among them one from the advisor to the US president’s SA equivalent, Dr Glenda Gray.
Research in England suggests 50-70% fall in hospitalization risk, reports Jason Douglas of The Wall Street Journal.
The implementation of Covid-19 vaccine booster doses have been approved for those who have received their initial series of J&J or Pfizer vaccines.
Researchers estimate the risk of hospitalisation from the new variant is lower than with the Delta strain, reports The Wall Street Journal.
“Surviving serious Covid-19 disease does not seem to happen often. It is therefore with much gratitude and thanksgiving that I look back.”
“My critique of PANDA and its head honcho, Nick Hudson, prompted a manifesto of prodigious length. In many ways, it simply underscores my concerns.”
“Fewer patients admitted with severe disease but more young children being treated, as experts warn firmer conclusions will need more time.”
Elsabé Klinck picks up on a thorny issue for freedom-loving South Africans – the proposed introduction of mandatory Covid-19 vaccines.